1-8 of 8
Andrew Aw
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A post hoc safety analysis of fixed-duration acalabrutinib-venetoclax combinations vs chemoimmunotherapy: Results from the phase 3 AMPLIFY trial

Free
John Seymour, Andrew Aw, Vincent Ribrag, Guillaume Cartron, Arnon Kater, Ki-Seong Eom, Alan Skarbnik, Alessandra Tedeschi, Malgorzata Wach, Jing-Zhou Hou, Arpad Illes, Batul Suterwala, Jiefen Munley, Ellie John, Toshifumi Fujimori, Jennifer Brown
Journal: Blood
Blood (2025) 146 (Supplement 1): 2118.
https://doi.org/10.1182/blood-2025-2118
Published: 2025
Journal Articles

Fixed-Duration Acalabrutinib Plus Venetoclax with or without Obinutuzumab Versus Chemoimmunotherapy for First-Line Treatment of Chronic Lymphocytic Leukemia: Interim Analysis of the Multicenter, Open-Label, Randomized, Phase 3 AMPLIFY Trial

Free
Jennifer R. Brown, John F. Seymour, Wojciech Jurczak, Andrew Aw, Malgorzata Wach, Arpad Illes, Alessandra Tedeschi, Carolyn Owen, Alan P Skarbnik, Daniel Lysak, Ki-Seong Eom, Martin Šimkovič, Miguel Arturo Pavlovsky, Arnon P. Kater, Barbara F. Eichhorst, Kara Miller, Veerendra Munugalavadla, Ting Yu, Marianne de Borja, Paolo Ghia
Journal: Blood
Blood (2024) 144 (Supplement 1): 1009.
https://doi.org/10.1182/blood-2024-200701
Published: 2024
Journal Articles

Quality of Life in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice across Canada: Results from the Devote Study

Free
Andrew Aw, Versha Banerji, Sarah-Jane Bull, Pierre-André Fournier, Anthea Peters, Carolyn Owen
Journal: Blood
Blood (2022) 140 (Supplement 1): 12425–12426.
https://doi.org/10.1182/blood-2022-156749
Published: 2022
Journal Articles

Tumor Lysis Syndrome: Incidence, Mitigation and Management in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice (DEVOTE) across Canada

Free
Versha Banerji, Nizar Abdel-Samad, Andrew Aw, Sarah-Jane Bull, Pierre-André Fournier, Nathalie Johnson, Nicole B. Laferriere, Paola Lembo, Christina H Pelizon, Anthea Peters, Carolyn Owen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3744.
https://doi.org/10.1182/blood-2021-146001
Published: 2021
Journal Articles

Bendamustine and Rituximab Versus Conventional Chemoimmunotherapy As a Frontline Treatment for Patients with Indolent B-Cell Lymphoma: A Cost-Effectiveness Analysis

Free
Andrew Aw, MD MEng, FRCPC, Kathryn Coyle, BScPharm, MSc, Isabelle Bence-Bruckler, MD FRCPC, Christopher N. Bredeson, MD MSc, FRCPC, Doug Coyle, MA, MSc, PhD
Journal: Blood
Blood (2016) 128 (22): 1186.
https://doi.org/10.1182/blood.V128.22.1186.1186
Published: 2016
Journal Articles

Combined Modality Therapy in the Upfront Treatment of Patients with Primary Central Nervous System Lymphoma: A Systematic Review

Free
Andrew Aw, MD FRCPC, Lee Mozessohn, MD FRCPC, Isabelle Bence-Bruckler, MD FRCPC, Rena Buckstein, MD FRCPC, Matthew Cheung, MD SM, FRCPC
Journal: Blood
Blood (2015) 126 (23): 5606.
https://doi.org/10.1182/blood.V126.23.5606.5606
Published: 2015
Journal Articles

Identification and Management of Glucocorticoid-Induced Hyperglycemia on an Inpatient Malignant Hematology Ward: A Quality Improvement Initiative

Free
Andrew Aw, MDM, MEng, Heidi Dutton, MD, Janine Malcolm, MD, Erin Keely, MD, Jason Tay, MD MSc
Journal: Blood
Blood (2014) 124 (21): 6004.
https://doi.org/10.1182/blood.V124.21.6004.6004
Published: 2014
Journal Articles

Incidence and Predictive Factors of Symptomatic Thrombosis Related to Peripherally Inserted Central Catheters In Chemotherapy Patients

Free
Andrew Aw, MD, MEng, Joshua Koczerginski, BSc, Sheryl McDiarmid, BScN, MEd, Marc Carrier, MD, MSc, Jason Tay, MD, MSc
Journal: Blood
Blood (2010) 116 (21): 4206.
https://doi.org/10.1182/blood.V116.21.4206.4206
Published: 2010